e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Treatment of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary artery diameter and pulsatility did not decrease after vasodilator therapy lasting two years
P. Bracciale, F. Valerio, S. Bellanova, G. Valerio, L. Mangiacotti, A. G. D‘Agostino (San Pietro Vernotico, Lecce, Brindisi, Italy)
Source:
Annual Congress 2011 - Treatment of pulmonary hypertension
Session:
Treatment of pulmonary hypertension
Session type:
Thematic Poster Session
Number:
2380
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Bracciale, F. Valerio, S. Bellanova, G. Valerio, L. Mangiacotti, A. G. D‘Agostino (San Pietro Vernotico, Lecce, Brindisi, Italy). Pulmonary artery diameter and pulsatility did not decrease after vasodilator therapy lasting two years. Eur Respir J 2011; 38: Suppl. 55, 2380
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The pulmonary artery pulsatility index correlates with ventriculo-vascular coupling and elevated filling pressures in patients with pulmonary arterial hypertension.
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Year: 2018
Diastolic pulmonary artery pressure (dPAP) at three months post pulmonary endarterectomy (PEA) as a new prognostic factor
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Prognostic value of systolic pulmonary artery pressure change at exercise in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study
Source: Eur Respir J 2007; 29: 476-481
Year: 2007
Pulmonary artery distensibility correlates with functional response to sildenafil in distal chronic thrombo-embolic pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Carotid artery diameter and distensibility of ex-preterm infants with chronic lung disease at 8-12 years
Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease
Year: 2009
Exercise capacity and pulmonary artery pressure-flow relations in patients after successful pulmonary endarterectomy
Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Year: 2009
Fatal dissection of the pulmonary artery in pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 181-185
Year: 2009
Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience
Source: Eur Respir Rev 2017; 26: 160055
Year: 2017
Hemodynamic correlates of right ventricular afterload and pulmonary artery pulsatility under treatment with prostacyclin: Retrospective analysis of changes from baseline in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
Pulmonary artery diameter to predict pulmonary hypertension in pulmonary sarcoidosis
Source: Eur Respir J 2016; 47: 673-676
Year: 2016
Resting pulmonary artery pressure of 21–24 mmHg predicts abnormal exercise haemodynamics
Source: Eur Respir J 2016; 47:1436-1444
Year: 2016
Pulmonary arterial hypertension and coronary artery stenosis in neurofibromatosis
Source: Eur Respir J 2001; 18: Suppl. 33, 416s
Year: 2001
Effects of suramin on cardiopulmonary capacity and pulmonary venous contraction in pulmonary arterial hypertension
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
An investigation of correlation between diameter and pressure of pulmonary artery in pulmonary hipertension cases due to biomass smoke
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Dependence of mean pulmonary artery pressure from cytokine inflammation activity and remodeling index of pulmonary circulation
Source: Eur Respir J 2006; 28: Suppl. 50, 657s
Year: 2006
The association between resting and mild-to-moderate exercise pulmonary artery pressure
Source: Eur Respir J 2012; 39: 313-318
Year: 2012
Patterns of mean pulmonary artery pressure (mPAP)-flow relation changes following chronic therapy in idiopathic pulmonary arterial hypertension (IPAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 427s
Year: 2006
Pulmonary arterial compliance and exercise capacity after pulmonary endarterectomy
Source: Eur Respir J 2014; 43: 1403-1409
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept